chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation delayed
Clinical narrative: Heavy period/bleeding; ''My'' current period was 2 days late (started 2 cycles ago); This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19May2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included ADD (attention deficit disorder), depression and anxiety and known allergies to penicillin. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications included methylphenidate (MANUFACTURER UNKNOWN), for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 01Jun2021, the patient experienced heavy period/bleeding, her current period was 2 days late (started 2 cycles ago). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event heavy period/bleeding; her current period was 2 days late (started 2 cycles ago) was unknown at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Jun2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Intermenstrual bleeding, Menstruation irregular
Clinical narrative: Bleed very heavy; I essentially had 2 periods in one month, a little more than 2 weeks apart; Spotting; Painful cramping in stomach/  The cramping was more painful than normal.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Jun2021 at 08:39 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE) and unspecified multivitamins; both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient reported that the first day of her menstrual cycle for June2021 was 02Jun2021 and ended on 06Jun2021. On 19Jun2021, the patient began to experience spotting and painful cramping in stomach. On 20Jun2021, the patient began to bleed very heavy. On 24Jun2021, the bleeding lessened to spotting. She does not have irregular bleeding, as cycle was normal and like clockwork. The patient essentially had 2 periods in one month, a little more than 2 weeks apart. The cramping was more painful than normal. The events did not in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of event began to bleed very heavy was resolved on 23Jun2021and began to experience spotting, had 2 periods in one month, a little more than 2 weeks apart, cramping was more painful than normal and painful cramping in stomach was resolved on an unknown date in Jun2021.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Very loose stool within 3 hours of vaccine; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the right arm on 24Jun2021 at 12:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included citalopram (MANUFACTURER UNKNOWN), vitamin d nos (VIT D), magnesium (MANUFACTURER UNKNOWN) and propylene glycol (MANUFACTURER UNKNOWN); all for unknown indication from unknown date unknown if ongoing. On 24Jun2021 at 15:30, within 3 hours of vaccine, the patient experienced very loose stool. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very loose stool within 3 hours of vaccine was unknown at the time of this report.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dizziness exertional, Headache, Pain
Clinical narrative: Worst headache; Fevers; Chills; Body aches; DOE; Chest pain; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the right arm on 11Jun2021 at 20:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to seafood, pollen and selected chemicals. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On 20Jun2021 at 12:30, the patient experienced worst headache, fevers, chills, body aches, DOE (dyspnea on exertion) and chest pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event worst headache, fevers, chills, body aches, DOE (dyspnea on exertion) and chest pain was not resolved at the time of this report.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Worst headache; Fevers; Chills; Body aches; DOE; Chest pain; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the right arm on 11Jun2021 at 20:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to seafood, pollen and selected chemicals. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On 20Jun2021 at 12:30, the patient experienced worst headache, fevers, chills, body aches, DOE (dyspnea on exertion) and chest pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event worst headache, fevers, chills, body aches, DOE (dyspnea on exertion) and chest pain was not resolved at the time of this report.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Hypoaesthesia, Tremor
Clinical narrative: Left sided chest pain; Discomfort on the left chest; Shaking; Left side slight numbness; This is a spontaneous report from a contactable pharmacist, the patient. A 39-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 25Jun2021 at 12:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 25Jun2021 at 23:00, the patient experienced left sided chest pain, discomfort on the left chest, shaking and left side slight numbness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left sided chest pain, discomfort on the left chest, shaking and left side slight numbness was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Migraine, Nausea
Clinical narrative: Migraine; Body aches; Stomach cramps; Nausea; Diarrhea; Chills; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0181) via an unspecified route of administration in the right arm on 25Jun2021 at 16:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0180) via an unspecified route of administration in the right arm on 04Jun2021 at 12:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. On 26Jun2021 at 04:00, the patient experienced second dose effects which included migraine, nausea, diarrhea, chills, body aches, stomach cramps, sore arm. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, nausea, diarrhea, chills, body aches, stomach cramps, sore arm was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Migraine; Body aches; Stomach cramps; Nausea; Diarrhea; Chills; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0181) via an unspecified route of administration in the right arm on 25Jun2021 at 16:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0180) via an unspecified route of administration in the right arm on 04Jun2021 at 12:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. On 26Jun2021 at 04:00, the patient experienced second dose effects which included migraine, nausea, diarrhea, chills, body aches, stomach cramps, sore arm. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, nausea, diarrhea, chills, body aches, stomach cramps, sore arm was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Feeling abnormal, Muscle tightness, SARS-CoV-2 test
Clinical narrative: The back of right leg is extremely tight only on the backside; The back of right leg is extremely tight only on the backside and has a burning sensation. The lower back side is have the same sensation.; It is progressing with all of these sensations, very strange.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO181) via an unspecified route of administration in the left arm on 25Jun2021 at 15:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included services (as reported). Prior to the vaccination, the patient was not diagnosed with COVID-19. On 01Dec2020, the patient underwent Covid-19 test via nasal swab and the result found to be negative. The patient did not receive other vaccines within 4 weeks prior to the vaccination. Concomitant medications included felbamate (MANUFACTURER UNKNOWN); lamotrigine (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN), all taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received morphine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 26Jun2021 at 04:00, the patient experienced that the back of her right leg was extremely tight only on the backside and had a burning sensation. The lower back side was having the same sensation. It was progressing with all of these sensations, very strange. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events the back of right leg was extremely tight, only on the backside and had a burning sensation, the lower back side was having the same sensation, progressing with all of these sensations, very strange was not resolved at the time of this report.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Muscle spasms
Clinical narrative: Heavy period. Currently has lasted twice as long as normal. (Still ongoing); Severe cramping; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0181) via an unspecified route of administration in the left arm on 17Jun2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On 20Jun2021, the patient experienced heavy period, currently had lasted twice as long as normal (still ongoing) and severe cramping. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events heavy period, currently had lasted twice as long as normal (still ongoing) and severe cramping were not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Hypoaesthesia
Clinical narrative: body went very numb like; a very uncontrollable bowel movement (diarrhea); This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 16Mar2021 at 00:30 (at the age of 65-year-old), as a single dose for COVID-19 immunisation. Medical history included heart failure, atrial fibrillation (A-fib) and diabetes and known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included unspecified blood thinners and metformin (MANUFACTURER UNKNOWN), etc; all for unknown indications from unknown dates and unknown if ongoing. The patient previously received iodine (MANUFACTURER UNKNOWN) for unknown indication from unknown date and experienced drug allergy and received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6203) via an unspecified route of administration in the left arm on 23Feb2021 at 08:00 (at the age of 65-year-old), as a single dose for COVID-19 immunisation. On 16Mar2021 at 18:00, 8 hours after second shot, the patient's body went very numb like and proceeded to have a very uncontrollable bowel movement (diarrhea). The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body went very numb like and a very uncontrollable bowel movement (diarrhea) was resolved on an unknown date in 2021.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Severe swelling of lymph nodes under left underarm with pain; Severe swelling of lymph nodes under left underarm with pain; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the left arm on an unknown date in Jun2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity, depression and hidradenitis suppurativa. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included losartan (MANUFACTURER UNKNOWN), montelukast sodium (MONTELUCAST) and escitalopram (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient previously received clindamycin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW021) via an unspecified route of administration in the left arm on 05Jun2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 27Jun2021, the patient experienced severe swelling of lymph nodes under left underarm with pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe swelling of lymph nodes under left underarm with pain was not resolved at the time of this report.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea
Clinical narrative: No menses for 3 months after last Pfizer vaccine; This is a spontaneous report from a contactable other healthcare professional, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 06Mar2021 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an intramuscular route of administration in the left arm on an unknown date at 14:00 as a single dose for COVID-19 immunisation. On 01Apr2021, the patient experienced no menses for 3 months after last Pfizer vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of no menses for 3 months and included treatment with medroxyprogesterone acetate (PROVERA) 10mg oral tablet to start her menses. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event no menses for 3 months after last Pfizer vaccine was unknown at the time of this report.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Hypoaesthesia, Influenza like illness, Joint swelling
Clinical narrative: An hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and ting; An hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and ting; flu like symptoms; Fever; body aches; Pain and Swelling in injection sight( my shoulder, shoulder blade, and my right arm to my elbow was swollen); Pain and Swelling in injection sight( my shoulder, shoulder blade, and my right arm to my elbow was swollen); nausea; diarrhea; headache; my elbow was swollen; This is a spontaneous report from a contactable consumer (patient herself).   A 26-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: Ew0191, Expiry date was not reported), via an unspecified route, administered in Arm Right on 09Jun2021 15:00 (Age at vaccination 26-years-old) as dose 1, single for covid-19 immunization. The facility type vaccine was clinic. The patient was not pregnant at time of vaccination. Medical history included osteogenesis imperfecta, had papillary carcinoma of the thyroid and had the right side removed, scoliosis from an unknown date and unknown if ongoing, known allergies: tegaderm, covid-19 from an unknown date and unknown if ongoing. There were no concomitant medications. On 19Jun2021 16:00, the patient experienced an hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and tingly. Within an hour of this symptoms, they went away without medical attention. I also had flu like symptoms, fever, body aches, pain and swelling in injection sight (my shoulder, shoulder blade, and my right arm to my elbow was swollen), nausea, diarrhea, headache. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not received any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received treatment for the events. The clinical outcome of the events an hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and tingly was recovered on 09Jun2021 and rest of the events was recovered on an unspecified date.  Follow-up attempts are completed. No further information is expected
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Paraesthesia, Pyrexia, Vaccination site pain
Clinical narrative: An hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and ting; An hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and ting; flu like symptoms; Fever; body aches; Pain and Swelling in injection sight( my shoulder, shoulder blade, and my right arm to my elbow was swollen); Pain and Swelling in injection sight( my shoulder, shoulder blade, and my right arm to my elbow was swollen); nausea; diarrhea; headache; my elbow was swollen; This is a spontaneous report from a contactable consumer (patient herself).   A 26-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: Ew0191, Expiry date was not reported), via an unspecified route, administered in Arm Right on 09Jun2021 15:00 (Age at vaccination 26-years-old) as dose 1, single for covid-19 immunization. The facility type vaccine was clinic. The patient was not pregnant at time of vaccination. Medical history included osteogenesis imperfecta, had papillary carcinoma of the thyroid and had the right side removed, scoliosis from an unknown date and unknown if ongoing, known allergies: tegaderm, covid-19 from an unknown date and unknown if ongoing. There were no concomitant medications. On 19Jun2021 16:00, the patient experienced an hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and tingly. Within an hour of this symptoms, they went away without medical attention. I also had flu like symptoms, fever, body aches, pain and swelling in injection sight (my shoulder, shoulder blade, and my right arm to my elbow was swollen), nausea, diarrhea, headache. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not received any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received treatment for the events. The clinical outcome of the events an hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and tingly was recovered on 09Jun2021 and rest of the events was recovered on an unspecified date.  Follow-up attempts are completed. No further information is expected
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: An hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and ting; An hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and ting; flu like symptoms; Fever; body aches; Pain and Swelling in injection sight( my shoulder, shoulder blade, and my right arm to my elbow was swollen); Pain and Swelling in injection sight( my shoulder, shoulder blade, and my right arm to my elbow was swollen); nausea; diarrhea; headache; my elbow was swollen; This is a spontaneous report from a contactable consumer (patient herself).   A 26-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: Ew0191, Expiry date was not reported), via an unspecified route, administered in Arm Right on 09Jun2021 15:00 (Age at vaccination 26-years-old) as dose 1, single for covid-19 immunization. The facility type vaccine was clinic. The patient was not pregnant at time of vaccination. Medical history included osteogenesis imperfecta, had papillary carcinoma of the thyroid and had the right side removed, scoliosis from an unknown date and unknown if ongoing, known allergies: tegaderm, covid-19 from an unknown date and unknown if ongoing. There were no concomitant medications. On 19Jun2021 16:00, the patient experienced an hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and tingly. Within an hour of this symptoms, they went away without medical attention. I also had flu like symptoms, fever, body aches, pain and swelling in injection sight (my shoulder, shoulder blade, and my right arm to my elbow was swollen), nausea, diarrhea, headache. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not received any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received treatment for the events. The clinical outcome of the events an hour after receiving my first dose of the Pfizer vaccine in my right arm; my entire right arm, right side of my neck, right side of my face, and whole right side of head went entirely numb and tingly was recovered on 09Jun2021 and rest of the events was recovered on an unspecified date.  Follow-up attempts are completed. No further information is expected
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Breast tenderness, Menstruation irregular, Premenstrual pain
Clinical narrative: Period came uncharacteristically early; The cramps were more severe and breasts were tender for a couple days prior; The cramps were more severe and breasts were tender for a couple days prior; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 06May2021 at 15:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 15Apr2021 at 15:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. On 19Jun2021, a couple days prior to her period, the patient experienced cramps which were more severe and breasts were tender, which was not something that has happened for the patient before. On 21Jun2021, the patient experienced period which came uncharacteristically early. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events period came uncharacteristically early, the cramps were more severe and breasts were tender for a couple days prior which was not something that has happened for the patient before was unknown at the time of this report.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: Severe chills; Headache; Fatigue; Late night stomach cramps; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0198) via an unspecified route of administration in the left  arm on 05Jul2021 at 20:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included supraventricular tachycardia (SVT). The patient had known allergies to iodine, penicillin and shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included propranolol (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0180), via an unspecified route of administration in the left arm on 14Jun2021 at 10:00 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Jul2021 at 10:00, about 14 hours after 2nd dose the patient experienced severe chills, headache, fatigue, then late night stomach cramps and then diarrhea. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event severe chills, headache, fatigue, late night stomach cramps and diarrhea were resolving at the time of this report.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: The day after the shot, I woke up with extreme burning pain in both arms and hands, a fever, and a mild headache; Fever; Mild headache; I have since developed tingling; Numbness; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 02Apr2021 at 17:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis, hypothyroid (non-autoimmune type), generalized joint hypermobility and scoliosis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included low estrogen (MANUFACTURER UNKNOWN) for birth control and levothyroxine (MANUFACTURER UNKNOWN) taken for an unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 10Mar2021 at 15:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 03Apr2021 at 06:00, the day after the shot, the patient woke up with extreme burning pain in both arms and hands, a fever, and a mild headache. All resolved within 2 days, but since then on an unknown date in Apr2021 the patient developed tingling, numbness, and weakness, particularly in her right (dominant) hand. At first it was most intense in the morning, but then came and gone. It was further reported that if patient did anything very physical with her hands (such as pull weeds), the burning returned. The patient had no prior history of this and it developed suddenly after the shot. The patient had not seen her PCP (primary care physician), but since it has been getting more debilitating, the patient planned to see her by the end of this month. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events the patient woke up with extreme burning pain in both arms and hands, tingling, numbness and weakness were not resolved while the events a fever, and a mild headache were resolved on 05Apr2021 at the time of this report.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: The day after the shot, I woke up with extreme burning pain in both arms and hands, a fever, and a mild headache; Fever; Mild headache; I have since developed tingling; Numbness; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 02Apr2021 at 17:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis, hypothyroid (non-autoimmune type), generalized joint hypermobility and scoliosis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included low estrogen (MANUFACTURER UNKNOWN) for birth control and levothyroxine (MANUFACTURER UNKNOWN) taken for an unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 10Mar2021 at 15:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 03Apr2021 at 06:00, the day after the shot, the patient woke up with extreme burning pain in both arms and hands, a fever, and a mild headache. All resolved within 2 days, but since then on an unknown date in Apr2021 the patient developed tingling, numbness, and weakness, particularly in her right (dominant) hand. At first it was most intense in the morning, but then came and gone. It was further reported that if patient did anything very physical with her hands (such as pull weeds), the burning returned. The patient had no prior history of this and it developed suddenly after the shot. The patient had not seen her PCP (primary care physician), but since it has been getting more debilitating, the patient planned to see her by the end of this month. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events the patient woke up with extreme burning pain in both arms and hands, tingling, numbness and weakness were not resolved while the events a fever, and a mild headache were resolved on 05Apr2021 at the time of this report.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder
Clinical narrative: "I" had not menstruated in almost a year prior to "my" second vaccine. Since then, "I" had light bleeding, twice, about 3 weeks apart.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 23Apr2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT), taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On an unknown date in 2021, since the second dose, the patient experienced light bleeding, twice, about 3 weeks apart. The patient reported that she had not menstruated in almost a year prior to her second vaccine. She now had a period like she had years ago. Her first dose was on 29Mar2021 and second dose on 23Apr2021. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event had light bleeding, twice, about 3 weeks apart, had not menstruated in almost a year prior to the second vaccine was unknown at the time of this report.
Age: 57.0
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Ultrasound scan
Clinical narrative: Prolonged and severe upper left arm pain.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old patient of unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on 17Apr2021 at 10:00(at the age of 57-years-old) as a single dose for COVID-19 immunisation. The medical history included fibromyalgia, high blood pressure (HBP) and allergy to a blood pressure (BP) medicine and an unspecified medicine for acid reflux. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included amlodipine (MANUFACTURER UNKNOWN) and gabapentin (MANUFACTURER UNKNOWN), all from unknown dates for unspecified indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on an unknown date in Mar2021 at 09:00(at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient previously took pregabalin (LYRICA) and experienced allergy. On 23Apr2021, the patient experienced prolonged and severe upper left arm pain. On an unknown date, the patient underwent ultrasound testing and the result was not reported. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported event included treatment with lidocaine patch(MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event prolonged and severe upper left arm pain was not resolved at the time of this report.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Parosmia
Clinical narrative: Having a metallic taste after 2nd Dose/the metallic taste & smell of foods that are starch such as crackers, bread, chips, french fries and batter on chicken; The metallic taste & smell of foods that are starch such as crackers, bread, chips, french fries, and batter on chicken; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 11Apr2021 at 08:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included early onset of macular degeneration. The patient had a cold in Jan2021 and lost some since of taste or smell. But after the cold symptoms disappeared taste and smell came back. Never had fever, cough or breathing problems. The patient was not ever diagnosed as having COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6199) via an unspecified route of administration in the left arm on 14Mar2021 at 09:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 09:00, the patient had a metallic taste after second dose. The metallic taste and smell of foods that are starch such as crackers, bread, chips, french fries, and batter on chicken. If she had dipped the fries and chicken in ketchup or dressings, she could cover the bad taste. The patient had no problems with fruit or vegetables. Still had as of 07Jul2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events had a metallic taste after second dose/ the metallic taste and smell of foods that are starch such as crackers, bread, chips, french fries and batter on chicken was not resolved at the time of this report.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Malaise
Clinical narrative: Tiredness; Diarrhea; Not feeling well; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0181) via an unspecified route of administration in the right arm on 06Jul2021 at 09:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included type II diabetes and cardio vascular disease. The patient had unspecified allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 08Jul2021, the patient experienced tiredness, diarrhea and did not feel well. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events tiredness, diarrhea and not feeling well was not resolved at the time of this report.